This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
An anti-influenza combined therapy assessed by single cell RNA-sequencing
Communications Biology Open Access 10 October 2022
-
O-cyclic phytosphingosine-1-phosphate stimulates HIF1α-dependent glycolytic reprogramming to enhance the therapeutic potential of mesenchymal stem cells
Cell Death & Disease Open Access 05 August 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Galani, I. E. et al. Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity http://dx.doi.org/10.1016/j.immuni.2017.04.025 46, 875–890 (2017)
Rights and permissions
About this article
Cite this article
Minton, K. IFNλ offers frontline protection. Nat Rev Immunol 17, 404–405 (2017). https://doi.org/10.1038/nri.2017.70
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri.2017.70
This article is cited by
-
An anti-influenza combined therapy assessed by single cell RNA-sequencing
Communications Biology (2022)
-
O-cyclic phytosphingosine-1-phosphate stimulates HIF1α-dependent glycolytic reprogramming to enhance the therapeutic potential of mesenchymal stem cells
Cell Death & Disease (2019)